Drug General Information (ID: DDIIUEXDT0)
  Drug Name Valproic acid Drug Info Phenylbutyric acid Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Anticonvulsants Antihyperammonia Agents
  Structure

 Mechanism of Valproic acid-Phenylbutyric acid Interaction (Severity Level: Major)
     Antagonize the effect of anti-hyperammonemia agents Click to Show/Hide Mechanism Graph
      Drug Name Valproic acid Phenylbutyric acid
      Mechanism Hyperammonemia Anti-hyperammonemia agent
      Key Mechanism Factor 1
Factor Name Anti-hyperammonemia agents
Factor Description Anti-hyperammonemic agents may be less effective in acute hyperammonemia, leading to the development of hyperammonemic encephalopathy, which can sometimes be fatal.
      Mechanism Description
  • Antagonize the effect of Phenylbutyric acid when combined with Valproic acid 

Recommended Action
      Management Valproic acid should generally not be given to patients receiving phenylbutyrate therapy, as the use of valproic acid is considered contraindicated in patients with urea cycle disorders.

References
1 Product Information. Depakene (valproic acid). Abbott Pharmaceutical, Abbott Park, IL.
2 Product Information. Ravicti (glycerol phenylbutyrate). Hyperion Therapeutics Inc, South San Francisco, CA.
3 Product Information. Depakote (divalproex sodium). Abbott Pharmaceutical, Abbott Park, IL.